# Filing Detail

Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-14-000604
Filing Date
2014-01-31
Accepted
2014-01-31 17:29:45
Documents
20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REGISTRATION STATEMENT | fs12014_actinium.htm | S-1 | 2901135
2 | CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION FILED JANUARY 7, 2014.** | fs12014ex3v_actinium.htm | EX-3.5 | 1063
3 | FORM OF COMMON STOCK WARRANT, DATED DECEMBER 27, 2013 AND JANUARY 10, 2014.** | fs12014ex4viii_actinium.htm | EX-4.8 | 117711
4 | FORM OF LOCK-UP AGREEMENT, DATED DECEMBER 27, 2013.** | fs12014ex4ix_actinium.htm | EX-4.9 | 21144
5 | ACTINIUM PHARMACEUTICALS, INC. AMENDED AND RESTATED 2013 STOCK PLAN.** | fs12014ex10xxxiii_actinium.htm | EX-10.33 | 275780
6 | ACTINIUM PHARMACEUTICALS, INC. AMENDED AND RESTATED 2013 EQUITY INCENTIVE PLAN.* | fs12014ex10xxxiv_actinium.htm | EX-10.34 | 169555
7 | FORM OF UNIT PURCHASE AGREEMENT, DATED DECEMBER 27, 2013 AND JANUARY 10, 2014.** | fs12014ex10xxxv_actinium.htm | EX-10.35 | 175724
8 | FORM OF SUBSCRIPTION AGREEMENT, DATED DECEMBER 27, 2013 AND JANUARY 10, 2014.** | fs12014ex10xxxvi_actinium.htm | EX-10.36 | 183175
9 | FORM OF REGISTRATION RIGHTS AGREEMENT, DATED DECEMBER 27, 2013 AND JANUARY 10, 2 | fs12014ex10xxxvii_actinium.htm | EX-10.37 | 173188
10 | LETTER AGREEMENT, DATED SEPTEMBER 4, 2013, BETWEEN ACTINIUM PHARMACEUTICALS, INC | fs12014ex10xxxviii_actinium.htm | EX-10.38 | 1916
11 | ACCOUNTANTS CONSENT | fs12014ex23i_actinium.htm | EX-23.1 | 4218
18 |  | img001_v1.jpg | GRAPHIC | 138925
19 |  | img003_v1.jpg | GRAPHIC | 142184
20 |  | img002_v1.jpg | GRAPHIC | 177499
| Complete submission text file | 0001213900-14-000604.txt |  | 13390317

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL | fil-20130930.xml | EX-101.INS | 1657439
13 | XBRL | fil-20130930.xsd | EX-101.SCH | 88179
14 | XBRL | fil-20130930_cal.xml | EX-101.CAL | 46616
15 | XBRL | fil-20130930_def.xml | EX-101.DEF | 303662
16 | XBRL | fil-20130930_lab.xml | EX-101.LAB | 619077
17 | XBRL | fil-20130930_pre.xml | EX-101.PRE | 437791

Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-193714 | Film No.: 14565833
SIC: 6770 Blank Checks